OAF0104 | Differentiated service delivery for people with HIV and non-communicable diseases: South African policy enabler for integration | Oral abstract session with live Q&A | Integration of HIV with other health services (including co-infections and NCDs) |
OAF0103 | The use of community paralegals to improve the HIV and TB treatment cascade: comparing approaches in Mozambique, Senegal, Ghana, Indonesia, and Kyrgyzstan | Oral abstract session with live Q&A | Legal advocacy tools and strategies |
OAF0102 | Ensuring HIV treatment continuity for Haitian migrants to the Dominican Republic during the COVID-19 pandemic | Oral abstract session with live Q&A | Migration |
OAE0505 | Integration of hepatitis B and C testing into HIV services: an opportunity to achieve dual elimination of viral hepatitis and HIV in Vietnam | Oral abstract session with live Q&A | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
OAE0504 | Successful transition to tenofovir/lamivudine/dolutegravir (TLD) in PEPFAR-supported countries | Oral abstract session with live Q&A | Implementation science of scaling up HIV treatment |
OAE0503 | Using the RE-AIM framework to evaluate the implementation and effectiveness of a WHO HEARTS based implementation strategy to integrate the management of hypertension into HIV care in Uganda | Oral abstract session with live Q&A | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
OAE0502 | Screening and treatment of common mental disorders at HIV clinics within the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium | Oral abstract session with live Q&A | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
OAE0406 | The economic returns of achieving the 2021-2030 AIDS targets to end the AIDS epidemic by 2030 | Oral abstract session with live Q&A | Economic evaluation and affordability assessments |
OAE0405 | Thailand national PrEP program: moving towards sustainability | Oral abstract session with live Q&A | Implementation science of scaling up prevention (including PrEP) |
OAE0404 | Estimated costs to address unmet financial needs for HIV pre-exposure prophylaxis, United States, 2018 | Oral abstract session with live Q&A | National financing analyses and financing mechanisms for HIV, hepatitis and STI programmes and services |